In vivo CRISPR screening in head and neck cancer reveals Uchl5 as an immunotherapy target.
Fu C, Saddawi-Konefka R, Chinai JM, Kim SY, Kammula AV, Perera JJ, Jiang A, Tiwari P, Kistler EN, Tang S, Luna SM, Colvin KJ, Dubrot J, Anderson S, Fetterman RA, Chuong CL, Lane-Reticker SK, Cheruiyot CK, Muscato AJ, Alipour Z, Adkins DR, Griffin GK, Bernstein BE, Egloff AM, Yates KB, Chernock RD, Gutkind JS, Uppaluri R, Manguso RT.
Fu C, et al. Among authors: alipour z.
Nat Commun. 2025 Sep 29;16(1):8572. doi: 10.1038/s41467-025-63592-y.
Nat Commun. 2025.
PMID: 41022734
Free PMC article.